These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 14685060)

  • 1. Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes.
    Orroth KK; Korenromp EL; White RG; Gavyole A; Gray RH; Muhangi L; Sewankambo NK; Quigley M; Wawer MJ; Whitworth JA; Grosskurth H; Habbema JD; Hayes RJ
    AIDS; 2003 Dec; 17(18):2653-60. PubMed ID: 14685060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study.
    White RG; Orroth KK; Korenromp EL; Bakker R; Wambura M; Sewankambo NK; Gray RH; Kamali A; Whitworth JA; Grosskurth H; Habbema JD; Hayes RJ
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1500-13. PubMed ID: 15602129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors.
    Orroth KK; Korenromp EL; White RG; Changalucha J; de Vlas SJ; Gray RH; Hughes P; Kamali A; Ojwiya A; Serwadda D; Wawer MJ; Hayes RJ; Grosskurth H
    Sex Transm Infect; 2003 Apr; 79(2):98-105. PubMed ID: 12690128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.
    Korenromp EL; White RG; Orroth KK; Bakker R; Kamali A; Serwadda D; Gray RH; Grosskurth H; Habbema JD; Hayes RJ
    J Infect Dis; 2005 Feb; 191 Suppl 1():S168-78. PubMed ID: 15627227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results.
    Orroth KK; White RG; Korenromp EL; Bakker R; Changalucha J; Habbema JD; Hayes RJ
    Sex Transm Dis; 2006 Sep; 33(9):536-44. PubMed ID: 16778738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
    Ng BE; Butler LM; Horvath T; Rutherford GW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in sexually transmitted diseases and condom use patterns among commercial sex workers in Fukuoka City, Japan 1990-93.
    Tanaka M; Nakayama H; Sakumoto M; Matsumoto T; Akazawa K; Kumazawa J
    Genitourin Med; 1996 Oct; 72(5):358-61. PubMed ID: 8976854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
    Wawer MJ; Gray RH; Sewankambo NK; Serwadda D; Paxton L; Berkley S; McNairn D; Wabwire-Mangen F; Li C; Nalugoda F; Kiwanuka N; Lutalo T; Brookmeyer R; Kelly R; Quinn TC
    AIDS; 1998 Jul; 12(10):1211-25. PubMed ID: 9677171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of risk behaviour for patients with sexually transmitted diseases and surveillance for human immunodeficiency virus in Kuala Lumpur, Malaysia.
    Lye MS; Archibald C; Ghazali AA; Low BT; Teoh BH; Sinniah M; Rus SC; Singh J; Nair RC
    Int J STD AIDS; 1994; 5(2):124-9. PubMed ID: 8031914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results.
    Grosskurth H; Mosha F; Todd J; Senkoro K; Newell J; Klokke A; Changalucha J; West B; Mayaud P; Gavyole A
    AIDS; 1995 Aug; 9(8):927-34. PubMed ID: 7576329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda.
    Ahmed S; Lutalo T; Wawer M; Serwadda D; Sewankambo NK; Nalugoda F; Makumbi F; Wabwire-Mangen F; Kiwanuka N; Kigozi G; Kiddugavu M; Gray R
    AIDS; 2001 Nov; 15(16):2171-9. PubMed ID: 11684937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: results of a behavioural risk-reduction programme.
    Jackson DJ; Rakwar JP; Richardson BA; Mandaliya K; Chohan BH; Bwayo JJ; Ndinya-Achola JO; Martin HL; Moses S; Kreiss JK
    AIDS; 1997 Jun; 11(7):903-9. PubMed ID: 9189216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials.
    Grosskurth H; Gray R; Hayes R; Mabey D; Wawer M
    Lancet; 2000 Jun; 355(9219):1981-7. PubMed ID: 10859054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findings.
    Kamali A; Kinsman J; Nalweyiso N; Mitchell K; Kanyesigye E; Kengeya-Kayondo JF; Carpenter LM; Nunn A; Whitworth JA
    Trop Med Int Health; 2002 Dec; 7(12):1053-63. PubMed ID: 12460397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline STD prevalence in a community intervention trial of the female condom in Kenya.
    Feldblum PJ; Kuyoh M; Omari M; Ryan KA; Bwayo JJ; Welsh M
    Sex Transm Infect; 2000 Dec; 76(6):454-6. PubMed ID: 11221128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Wilkinson D; Rutherford G
    Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based trials of sexually transmitted disease treatment: repercussions for epidemiology and HIV prevention.
    Hudson CP
    Bull World Health Organ; 2001; 79(1):48-58. PubMed ID: 11217667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception and prevalence of sexually transmitted diseases among adolescents and young adults in Uganda.
    Agyei WK; Epema EJ; Lubega M
    Int J Epidemiol; 1992 Oct; 21(5):981-8. PubMed ID: 1468863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population.
    Wagner HU; Van Dyck E; Roggen E; Nunn AJ; Kamali A; Schmid DS; Dobbins JG; Mulder DW
    Int J STD AIDS; 1994; 5(5):332-7. PubMed ID: 7819350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.